Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
Back in 1995, a landmark paper was published, which shaped the fibrosis literature for many years to come. During the characterization of a fibroblast-specific marker (FSP1) in the kidneys, an observation was made, which gave rise to the hypothesis that “fibroblasts in some cases arise from the loca...
Main Authors: | Attila Fintha, Ákos Gasparics, László Rosivall, Attila Sebe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00388/full |
Similar Items
-
Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
by: Francesco Salton, et al.
Published: (2019-03-01) -
Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer
by: Ákos Gasparics, et al.
Published: (2022-11-01) -
Biomechanics of TGFβ‐induced epithelial‐mesenchymal transition: implications for fibrosis and cancer
by: Joseph W O’Connor, et al.
Published: (2014-12-01) -
New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
by: Lili Sheng, et al.
Published: (2020-09-01) -
Epithelial-Mesenchymal Transition and its Role in Renal Fibrogenesis
by: Brij Mohan Kumar Singh, et al.
Published: (2022-08-01)